TC
ENFN

Trium Capital’s Enfusion, Inc. ENFN Stock Holding History

Trium Capital’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,739,870
Closed -$19.4M – 68
2025
Q1 		$19.4M Buy
+1,739,870
New +$19.2M 2.42% 6

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Trium Capital's ENFN Position: Q2 2025 in Review

Trium Capital sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,739,870 shares — an estimated $19.4M sold.

Trium Capital first reported a position in ENFN in Q1 2025 and held it in 1 quarter. The position peaked at $19.4M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Trium Capital reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Trium Capital sold 1,739,870 Enfusion, Inc. shares in Q2 2025, an estimated $19.4M.
  • Trium Capital first reported a position in Enfusion, Inc. in Q1 2025 and held it in 1 quarter.
  • Trium Capital's Enfusion, Inc. position peaked at $19.4M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Trium Capital's 13F filing for Q2 2025, filed 11 Aug 2025.